No Magic Mushroom Monopoly
No Magic Mushroom Monopoly Relax. No one is trying to monopolize magic mushrooms. COMPASS Pathways is not trying to monopolize magic mushrooms. Renewed interest in psychedelic medicine (e.g., psilocybin) is not part …
No Magic Mushroom Monopoly Relax. No one is trying to monopolize magic mushrooms. COMPASS Pathways is not trying to monopolize magic mushrooms. Renewed interest in psychedelic medicine (e.g., psilocybin) is not part …
COMPASS Pathways Targeting “Patient Access” to Synthetic Psilocybin COMPASS Pathways is a life sciences company, founded in 2016, to “accelerate patient access to evidence-based innovation in mental health.” According to their …
Microdosing Psilocybin with Psilocybin Mushrooms What does “microdosing” psilocybin mean? What is the state of the art for microdosing ? How can we improve the state of the art? What …
Microdosing Technology as of May 2018 Simone Kitchens recently wrote a “Microdosing Guide and Explainer” for New York Magazine’s “The Cut” because of its “spread from San Francisco to New York and …
Psilocybin for Improving Athletic Performance Can psilocybin be taken to improve athletic performance? Yes, probably. Psilocybin and other “psychedelics” have earned new fame as cognitive enhancers when taken in “sub-threshold” doses, …
Psilocybin Formulations for Treating Depression Many people suffering from depression would benefit from access to psilocybin. Anecdotal reports suggest that it could be a safe and effective option for treating …
Psychedelic Therapy NBC News ran a story in September 2017 about psilocybin and other so-called “psychedelic” drugs. From a chemical perspective, these molecules target the neurotransmitter serotonin, just like all …
In October 2017, Scientific Reports published an article titled “Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.” Psilocybin “Resets” Brain of Depressed People The researchers measured the effects of psilocybin by …